Memantine has demonstrated efficacy in suppressing premature atrial contractions in a phase II trial. The study showed a reduction in both atrial ectopy and overall atrial tachyarrhythmia ...
Patients, ≥18 years of age, were eligible for inclusion if they had at least one PAF episode documented by electrocardiogram (ECG) and a properly functioning Vitatron DDDR pacemaker with a bipolar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results